RETRACTED: Association of Initial Viral Load in Severe Acute Respiratory Syndrome Coronavirus 2 (BARS-CoV-2) Patients with Outcome and Symptoms (Retracted Article)

被引:128
作者
Argyropoulos, Kimon, V [1 ]
Serrano, Antonio [1 ]
Hu, Jiyuan [4 ]
Black, Margaret [1 ]
Feng, Xiaojun [1 ]
Shen, Guomiao [1 ]
Call, Melissa [5 ]
Kim, Min J. [5 ]
Lytle, Andrew [1 ]
Belovarac, Brendan [1 ]
Vougiouklakis, Theodore [1 ]
Lin, Lawrence H. [1 ]
Moran, Una [3 ,5 ]
Heguy, Adriana [1 ]
Troxel, Andrea [4 ]
Snuderl, Matija [1 ]
Osman, Iman [2 ,3 ,5 ]
Cotzia, Paolo [1 ,3 ]
Jour, George [1 ,2 ]
机构
[1] NYU Langone Hlth, Dept Pathol, New York, NY USA
[2] NYU Langone Hlth, Dept Dermatol, New York, NY USA
[3] NYU Langone Hlth, Ctr Biospecimen Res & Dev, New York, NY USA
[4] NYU Grossman Sch Med, Dept Populat Hlth, New York, NY USA
[5] NYU, Sch Med, Interdisciplinary Melanoma Program, New York, NY USA
关键词
SARS;
D O I
10.1016/j.ajpath.2020.07.001
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The dynamics of viral load (VL) of the severe acute respiratory syndrome coronavirus 2 and its association with different clinical parameters remain poorly characterized in the US patient population. Herein, we investigate associations between VL and parameters, such as severity of symptoms, disposition (admission versus direct discharge), length of hospitalization, admission to the intensive care unit, length of oxygen support, and overall survival in 205 patients from a tertiary care center in New York City. VL was determined using quantitative PCR and log10 transformed for normalization. Associations were tested with univariate and multivariate regression models. Diagnostic VL was significantly lower in hospitalized patients than in patients not hospitalized (log10 VL = 3.3 versus 4.0; P = 0.018) after adjusting for age, sex, race, body mass index, and comorbidities. Higher VL was associated with shorter duration of the symptoms in all patients and hospitalized patients only and shorter hospital stay (coefficient = -2.02, -2.61, and -2.18; P < 0.001, P = 0.002, and P = 0.013, respectively). No significant association was noted between VL, admission to intensive care unit, length of oxygen support, and overall survival. Our findings suggest a higher shedding risk in less symptomatic patients, an important consideration for containment strategies. Furthermore, we identify a novel association between VL and history of cancer. Larger studies are warranted to validate our findings.
引用
收藏
页码:1881 / 1887
页数:7
相关论文
共 16 条
[1]  
Cereda DTM, 2020, 200309320 ARXIV
[2]   Clinical progression of patients with COVID-19 in Shanghai, China [J].
Chen, Jun ;
Qi, Tangkai ;
Liu, Li ;
Ling, Yun ;
Qian, Zhiping ;
Li, Tao ;
Li, Feng ;
Xu, Qingnian ;
Zhang, Yuyi ;
Xu, Shuibao ;
Song, Zhigang ;
Zeng, Yigang ;
Shen, Yinzhong ;
Shi, Yuxin ;
Zhu, Tongyu ;
Lu, Hongzhou .
JOURNAL OF INFECTION, 2020, 80 (05) :E1-E6
[3]   COVID-19: Immunology and treatment options [J].
Felsenstein, Susanna ;
Herbert, Jenny A. ;
McNamara, Paul S. ;
Hedrich, Christian M. .
CLINICAL IMMUNOLOGY, 2020, 215
[4]  
He X, 2020, NAT MED, V26, DOI [10.1038/s41591-020-1016-z, 10.1038/s41591-020-0869-5]
[5]   SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor [J].
Hoffmann, Markus ;
Kleine-Weber, Hannah ;
Schroeder, Simon ;
Krueger, Nadine ;
Herrler, Tanja ;
Erichsen, Sandra ;
Schiergens, Tobias S. ;
Herrler, Georg ;
Wu, Nai-Huei ;
Nitsche, Andreas ;
Mueller, Marcel A. ;
Drosten, Christian ;
Poehlmann, Stefan .
CELL, 2020, 181 (02) :271-+
[6]   Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J].
Huang, Chaolin ;
Wang, Yeming ;
Li, Xingwang ;
Ren, Lili ;
Zhao, Jianping ;
Hu, Yi ;
Zhang, Li ;
Fan, Guohui ;
Xu, Jiuyang ;
Gu, Xiaoying ;
Cheng, Zhenshun ;
Yu, Ting ;
Xia, Jiaan ;
Wei, Yuan ;
Wu, Wenjuan ;
Xie, Xuelei ;
Yin, Wen ;
Li, Hui ;
Liu, Min ;
Xiao, Yan ;
Gao, Hong ;
Guo, Li ;
Xie, Jungang ;
Wang, Guangfa ;
Jiang, Rongmeng ;
Gao, Zhancheng ;
Jin, Qi ;
Wang, Jianwei ;
Cao, Bin .
LANCET, 2020, 395 (10223) :497-506
[7]   Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus [J].
Li, WH ;
Moore, MJ ;
Vasilieva, N ;
Sui, JH ;
Wong, SK ;
Berne, MA ;
Somasundaran, M ;
Sullivan, JL ;
Luzuriaga, K ;
Greenough, TC ;
Choe, H ;
Farzan, M .
NATURE, 2003, 426 (6965) :450-454
[8]  
Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI [10.1016/S1473-3099(15)00424-7, 10.1016/S1473-3099(20)30232-2]
[9]   The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic [J].
Osman, Iman ;
Cotzia, Paolo ;
Moran, Una ;
Donnelly, Douglas ;
Arguelles-Grande, Carolina ;
Mendoza, Sandra ;
Moreira, Andre .
JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18 (01)
[10]   Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study [J].
Peiris, JSM ;
Chu, CM ;
Cheng, VCC ;
Chan, KS ;
Hung, IFN ;
Poon, LLM ;
Law, KI ;
Tang, BSF ;
Hon, TYW ;
Chan, CS ;
Chan, KH ;
Ng, JSC ;
Zheng, BJ ;
Ng, WL ;
Lai, RWM ;
Guan, Y ;
Yuen, KY .
LANCET, 2003, 361 (9371) :1767-1772